| Literature DB >> 30882350 |
Élise Sourdeau1, Sylvain Clauser2, Romain Prud'Homme3, Valérie Bardet2, Leyla Calmette1.
Abstract
Acquired hemophilia A (AHA) is a rare and potentially severe bleeding disorder caused by circulating autoantibodies directed against factor (F) VIII. Apart from idiopathic cases, AHA is associated with autoimmune diseases, cancers, use of medications, pregnancy and the post-partum period. We report the case of a 78-year-old a male patient presenting with symptoms of a hematoma after a fall three days previously. He is medically followed for multiple myeloma and bullous pemphigoid. Laboratory investigations revealed isolated and recent increased of activated partial thromboplastin time (80,6/32,1s) and a markedly low FVIII activity (< 1%). The high-titer of FVIII inhibitor (19 Bethesda units/mL) confirmed the diagnosis of AHA diagnosis. The symptoms were noticeably alleviated following bortezomib, cyclophosphamide and dexamethasone therapy. This report describes a rare case of AHA associated with bullous pemphigoid and multiple myeloma. These pathologies induce an immunity modification that can predispose or be associated with the development of anti-FVIII inhibitors. This case illustrates two possible physiopathological hypotheses for the development of AHA, which will be discussed in this case report.Entities:
Keywords: acquired hemophilia A; bullous pemphigoid; myeloma
Mesh:
Substances:
Year: 2019 PMID: 30882350 DOI: 10.1684/abc.2018.1405
Source DB: PubMed Journal: Ann Biol Clin (Paris) ISSN: 0003-3898 Impact factor: 0.459